2024-05-06 20:41:40
The vaccine manufacturer Astrazeneca has admitted that “Vaxzevria” can have a serious side effect. This emerges from court documents in London, writes a newspaper.
A few days ago, a civil chamber of the Higher Regional Court (OLG) Bamberg sentenced the vaccine manufacturer Astrazeneca to provide comprehensive information about side effects of its corona vaccine “Vaxzevria”. Now the British daily newspaper “The Telegraph” reports that the company has already admitted a harmful side effect that was not previously listed – but before the London High Court, where Astrazeneca has to answer due to a class action lawsuit.
“In very rare cases it can cause TTS,” the newspaper quotes from the court document. TTS stands for thrombosis with thrombocytopenia syndrome. This leads to the formation of blood clots in rare places such as the brain or abdominal vessels and to a reduced blood platelet count.
TTS is a known possible complication after vaccination with Sars-CoV-2 vaccines. According to the Paul Ehrlich Institute, other vaccination reactions and side effects are primarily “temporary local reactions and general reactions” such as fatigue, fever, headaches, muscle pain or even chills. They are harmless and not associated with more serious or long-lasting illnesses.
Astrazeneca’s admission could lead to many individual plaintiffs being able to assert their claims for damages in addition to the class actions in Great Britain, the “Telegraph” and “Frankfurter Rundschau” estimate. There are currently 51 cases to be heard in London. This involves payments amounting to 100 million pounds.
The plaintiff suffered intestinal vein thrombosis
In Germany, a 33-year-old woman from Upper Franconia sued Astrazeneca. She was vaccinated with the Covid-19 vaccine from Astrazeneca in March 2021 and then suffered a so-called intestinal vein thrombosis. The woman fell into a coma and ultimately had to have part of her intestines removed.
She is demanding compensation and damages from the British-Swedish company. During the proceedings, the now successful lawsuit for information was added. Astrazeneca must provide the information for the period from December 27, 2020, when the vaccine was approved, to February 19, 2024.